Waters Corporation $WAT Stock Position Raised by Callan Family Office LLC

Key Points

• Callan Family Office LLC raised its stake in Waters Corporation by 152.0% in Q2, owning 1,444 shares valued at $504,000 as of the last reporting period.
• Waters Corporation's stock has a market cap of $19.85 billion, a P/E ratio of 30.07, and an average target price of $377.56 from analysts.
• Analysts have a mixed outlook on Waters, with two Strong Buy ratings, six Buy ratings, and nine Hold ratings, showing a general consensus of a Moderate Buy.

Callan Family Office LLC lifted its stake in shares of Waters Corporation (NYSE:WAT - Free Report) by 152.0% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,444 shares of the medical instruments supplier's stock after acquiring an additional 871 shares during the quarter. Callan Family Office LLC's holdings in Waters were worth $504,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of the stock. US Bancorp DE lifted its holdings in shares of Waters by 13.1% in the second quarter. US Bancorp DE now owns 2,681 shares of the medical instruments supplier's stock valued at $936,000 after purchasing an additional 310 shares in the last quarter. Maryland State Retirement & Pension System lifted its holdings in shares of Waters by 5.0% in the second quarter. Maryland State Retirement & Pension System now owns 2,894 shares of the medical instruments supplier's stock valued at $1,010,000 after purchasing an additional 139 shares in the last quarter. Shell Asset Management Co. lifted its holdings in shares of Waters by 107.3% in the second quarter. Shell Asset Management Co. now owns 5,247 shares of the medical instruments supplier's stock valued at $1,831,000 after purchasing an additional 2,716 shares in the last quarter. KLP Kapitalforvaltning AS lifted its holdings in shares of Waters by 11.8% in the second quarter. KLP Kapitalforvaltning AS now owns 22,692 shares of the medical instruments supplier's stock valued at $7,920,000 after purchasing an additional 2,400 shares in the last quarter. Finally, Eads & Heald Wealth Management lifted its holdings in shares of Waters by 4.0% in the second quarter. Eads & Heald Wealth Management now owns 1,282 shares of the medical instruments supplier's stock valued at $447,000 after purchasing an additional 49 shares in the last quarter. 94.01% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of analysts have recently issued reports on the company. JPMorgan Chase & Co. increased their target price on Waters from $300.00 to $325.00 and gave the company a "neutral" rating in a report on Thursday, October 9th. Robert W. Baird cut their price objective on Waters from $374.00 to $352.00 and set an "outperform" rating for the company in a report on Wednesday, July 16th. Redburn Partners set a $390.00 price objective on Waters in a report on Wednesday, October 8th. UBS Group reiterated a "neutral" rating on shares of Waters in a report on Tuesday, July 15th. Finally, Rothschild & Co Redburn started coverage on Waters in a report on Wednesday, October 8th. They set a "buy" rating and a $390.00 price objective for the company. Two equities research analysts have rated the stock with a Strong Buy rating, six have assigned a Buy rating and nine have given a Hold rating to the company. According to MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average target price of $377.56.

Waters Trading Down 0.9%

Shares of NYSE:WAT opened at $333.45 on Wednesday. The company has a market cap of $19.85 billion, a P/E ratio of 30.07, a P/E/G ratio of 3.14 and a beta of 1.04. The stock's 50-day moving average is $302.03 and its 200-day moving average is $323.46. Waters Corporation has a 52-week low of $275.05 and a 52-week high of $423.56. The company has a debt-to-equity ratio of 0.55, a quick ratio of 1.22 and a current ratio of 1.75.

Waters (NYSE:WAT - Get Free Report) last issued its quarterly earnings results on Thursday, May 19th. The medical instruments supplier reported $2.29 earnings per share (EPS) for the quarter. Waters had a return on equity of 38.60% and a net margin of 21.71%.The company had revenue of $608.55 million for the quarter. Equities research analysts predict that Waters Corporation will post 12.86 earnings per share for the current year.

About Waters

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Corporation (NYSE:WAT - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.